# Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

> **NCT00806195** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 7744 (actual)

## Conditions studied

- Meningitis
- Meningococcal Infection

## Interventions

- **BIOLOGICAL:** MenACWY-CRM197
- **BIOLOGICAL:** DTaP (Diptheria, Tetanus, Pertussis) Vaccine
- **BIOLOGICAL:** Hib (Haemophilus influenza b) Vaccine
- **BIOLOGICAL:** IPV (Inactivated Polio Vaccine) Vaccine
- **BIOLOGICAL:** Pneumococcal conjugate Vaccine
- **BIOLOGICAL:** MMR (Measles, Mumps, and Rubella) Vaccine
- **BIOLOGICAL:** Varicella Vaccine
- **BIOLOGICAL:** Hepatitis A Virus

## Key facts

- **NCT ID:** NCT00806195
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-11
- **Target enrollment:** 7744 (ACTUAL)
- **Last updated:** 2013-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806195, "Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00806195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*